-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Improving Interpretation of Genetic Testing for Hereditary Hemorrhagic, Thrombotic, and Platelet Disorders

Program: Education Program
Session: Advances in the Laboratory Assessment of Hemostatic and Thrombotic Disorders
Saturday, December 5, 2020, 7:25 AM-7:30 AM

Michele P. Lambert, MD

Department of Pediatrics, Division of Hematology, Children's Hosp. of Phila., Philadelphia, PA

Disclosures: Lambert: 22qSociety: Membership on an entity's Board of Directors or advisory committees; RDMD: Membership on an entity's Board of Directors or advisory committees; PDSA: Membership on an entity's Board of Directors or advisory committees, Research Funding; Octapharma: Consultancy, Honoraria, Research Funding; Aztra Zeneca: Research Funding; Rigel: Consultancy, Honoraria, Research Funding; Dova: Consultancy, Honoraria; Shionogi: Consultancy, Honoraria; Principia: Consultancy, Honoraria; Amgen: Consultancy, Honoraria; Novartis: Consultancy, Honoraria, Research Funding.

See more of: Advances in the Laboratory Assessment of Hemostatic and Thrombotic Disorders
See more of: Education Program
<< Previous Presentation | Next Presentation >>